AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
Gynecologic oncologist Nathalie D. McKenzie, MD, recently co-published a case study of a 31-year-old woman who presented with isolated primary Langerhans cell histiocytosis of the vulva and clitoris...
Shahram Mori, MD, recently co-published the results of a retrospective cohort study that compared myeloablative versus reduced-intensity conditioning regimens in allogeneic stem cell transplantation...
Deep brain stimulation (DBS), a surgical procedure to help relieve symptoms of movement disorders such as Parkinson’s disease and dystonia, has improved the quality of life for some patients, easing...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.